Mizuho analyst Ann Hynes raised the firm’s price target on Pediatrix Medical (MD) to $15 from $13 and keeps a Neutral rating on the shares following the “solid” Q3 report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MD: